Immunization with SV40-transformed cells yields mainly MHC-restricted monoclonal antibodies by unknown
IMMUNIZATION  WITH  SV40-TRANSFORMED  CELLS  YIELDS 
MAINLY  MHC-RESTRICTED  MONOCLONAL  ANTIBODIES 
BY  BARBARA G. FROSCHER AND  NORMAN R.  KLINMAN 
From the Department of Immunology, Scripps Clinic and Research Foundation, 
La JoUa, California 92037 
The  B cell  repertoire  has  been  classically defined as comprising  recognition 
specificities for antigens  per  se,  as  opposed to  the  T  cell  repertoire,  which  is 
dedicated to the recognition  of antigens primarily as they are presented on cell 
surfaces in the context of self MHC-encoded antigens (self +  X recognition) (1- 
3). Recently, evidence from several sources has indicated that self+ X recognition 
may also be characteristic  of a  component  of humoral  antibody responses (4- 
1 i). These studies have shown not only that,  in certain  instances,  stimulation of 
B cells requires antigen  presenting  cells of an appropriate  MHC haplotype (4- 
6),  but also that  some antibodies produced in  response to antigens  present  on 
cell surfaces recognize those antigens specifically in the context of the appropriate 
MHC alloantigens  (7-1 1). A  previous report from this laboratory described an 
extensive  analysis  of the  mAb  response  to  influenza  (PR8)-infected  syngeneic 
cells,  which  showed  that  ~30-60%  of the  responding  primary  splenic  B  cells 
yielded antibodies that bound PR8 antigens only in the context of infected cells 
expressing syngeneic MHC alloantigens (9). However, the contribution of B cells 
with  MHC-restricted  recognition  in  immune  responses in  general  is uncertain, 
as few studies have been conducted that could effectively identify and discrimi- 
nate  MHC-restricted antigen  recognition  in  the presence of recognition  of the 
antigen per se. 
In  this  paper  we  describe  the  monoclonal  B  cell  response  to  an  (SV40) 1- 
transformed  H-2 ~ fibroblast cell  line  (SV40-B6) (12).  The  majority of primary 
splenic B cells and slg- (surface Ig-negative) bone marrow precursor cells from 
C57BL/6  (H-2  b) and  from  BALB/c mice (H-2  d) responding  in  vitro  to  SV40- 
transformed  H-2  b cells  exhibit  MHC  +  X  recognition  in  that  their  antibody 
products uniquely bind SV40-transformed H-2  b cells. Furthermore,  the majority 
of these antibodies recognize SV40 transformation-specific antigens in association 
with the H-2 K b molecule, as defined by their ability to bind SV40-transformed 
A(5R) cells (KbDa), but not SV40-transformed HTG cells (KaDb). 
To study the fine specificities of these MHC-restricted antibodies, nine hybri- 
domas secreting mAb specific for the SV40-transformed H-2 syngeneic fibroblast 
cell line (SV40-B6) were derived from the fusion of SP2/0 cells with the progeny 
of antigenically  stimulated  primary  C57BL/6  splenic  B  cells.  The  reactivity 
patterns  of these nine  mAb were consistent with antibodies obtained from the 
' Abbreviations  used  in  this  paper:  DMEF,  supplemented DMEM;  s[g,  surface  Ig;  SV40,  simian 
virus 40. 
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splenic fragment culture  system, in that the majority of the antibodies (seven of 
the nine) were specific for SV40-transformed cells of the H-2  b haplotype, and in 
particular,  that  the  recognition  of six of these antibodies  was restricted  by the 
K b molecule. 
Materials and  Methods 
Mice.  C57BL/6 and BALB/c mice were obtained from the mouse breeding colony at 
Scripps Clinic and Research Foundation. Male and female mice 6-12 wk of age were used 
in the splenic fragment culture system and for construction of hybridomas. 
Cell Cultures.  SV40-transformed fibroblast cell lines of the following origins were a 
generous gift from Dr. Barbara Knowles (The Wistar Institute, Philadelphia, PA): C57BL/ 
6  (KbDb), A(5R)  (KbDn), HTG  (K~Db), bml,  bin3,  bin8,  bml0,  bmll  (12-14).  The 
chemically transformed cell line MC57 (KbD  b) is an independently derived fibroblast cell 
line  originating  from  C57BL/6  mice.  These  cell  lines  were  grown  in  DMEM  (M.  A. 
Bioproducts,  Los Angeles,  CA)  supplemented  with  10%  FCS,  2%  L-glutamine (Irvine 
Scientific, Irvine, CA) and 100 U/ml penicillin-streptomycin (Irvine Scientific) (DMEF) in 
a 5% COs atmosphere at 37°C. Cells were grown in DMEF with 5% Con A supernatant 
for 24 h before they were used to enhance the expression of cell surface MHC molecules. 
The Y3  hybridoma cell line,  which produces anti-H-2  b antibody, was derived by Dr. 
Charles Janeway (Yale University, New Haven, CT) and was obtained from Dr. Stanley 
Nathenson (Albert Enstein Medical College, Bronx, NY). 
Splenic Fragment  Cultures.  mAb specific for SV40-transformed B6  (SV40-B6) fibro- 
blasts were  produced  in  splenic  fragment cultures  as  previously described,  with  some 
modifications ~8, 9).  Briefly, 6-8-wk-old C57BL/6 or BALB/c mice were primed by i.p. 
injection of 10  SV40-B6 cells in alum. The SV40-B6 cells were grown in DMEF plus 5% 
Con  A  supernatant,  harvested  by scraping (rather  than  by trypsinization,  to preserve 
surface antigens), washed three times in sterile  PBS and irradiated at 3,000  rad before 
use. 5.0 ×  107 donor spleen or sIg- bone marrow cells (see below) from naive 6-12-wk- 
old  C57BL/6  or  BALB/c  mice  were  transferred  intravenously  into  SV40-B6  primed 
syngeneic recipient mice 4-6 wk after priming. The recipient mice received  1,300  rad 
whole body irradiation from a cesium source 1-4 h before donor cell transfer. 2-4 h after 
receiving donor cells,  recipient mice were injected  i.p.  with  107  irradiated  (3,000  rad) 
washed SV40-B6  fibroblasts in saline.  Fragment cultures were prepared from recipient 
spleens 16-20 h after cell transfer. Cultures were incubated at 37 °C in an atmosphere of 
93%  02  and  7%  CO2.  Medium  was  changed  every  2-4  d,  and  culture  fluids  were 
individually collected from days 9-30 and assayed for antibody activity. 
Depletion  of slg  + B  Cells from  Bone  Marrow.  sIg- cell  populations  from adult  bone 
marrow were prepared by a modification of the rosetting techniques of Walker et al. (15). 
In brief,  107-109 washed bone marrow cells  were incubated with a  5-10-fold excess of 
tanned, glutaraldehyde-fixed SRBC coated with goat anti-mouse IgM and IgG H  and L 
chain-specific antibodies (Kirkegaard and Perry Laboratories, Inc., Gaithersburg, MD). 
Rosetted bone marrow cells (sIg  ÷) were removed by centrifugation at 4°C through Ficoll- 
Hypaque  density  gradients.  30-50%  of the  input  bone  marrow  cells  were  generally 
recovered in the interface band. At least 90% of sIg  + lymphocytes were depleted by this 
method, and the resulting preparations possessed <2% sIg  ÷ lymphocytes, as assessed by 
direct fluorescence analysis employing fluorescein-labeled anti-mouse (IgM +  IgG +  IgA) 
rabbit Fab'2 fragments (Zymed Laboratories, Burlingame,  CA) on a  Becton-Dickenson 
FACS IV. 
Transfer Fusions.  Hybridoma lines were established using the SP2/0 cell line originally 
described by Shulman et al. (16) in a transfer fusion procedure similar to that previously 
described (17, 18). Normal B cell fusion partners were obtained by the following protocol. 
Recipient  C57BL/6  mice were primed  1-2  mo before use by the  i.p.  injection  of 107 
irradiated (3,000 rad) SV40-transformed H-2  b fibroblasts (SV40-B6) in alum, prepared as 
described above. Recipient mice were given  10 mg tetracycline i.p.  12 d before fusion. 5 
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given  108 donor spleen ceils intravenously. Donor spleen cells were obtained from 8-16- 
wk-old, conventionally reared naive C57BL/6 mice that had been given 10 mg tetracycline 
i.p. 7 d  earlier. 2  h  after the transfer of donor spleen ceils, recipient mice received  107 
irradiated (3,000 tad) SV40-B6 fibroblasts in saline i.p., and 2 h later, 10 mg tetracycline 
i.p. Recipient mice were fed water treated witb puromycin. 
5 d after cell transfers, the recipient mice were sacrificed, their spleens were removed, 
and a cell suspension was prepared. 8-40 x  10  6 nucleated cells were recovered per spleen, 
and  two  spleens  were  generally  pooled  per  fusion.  The  spleen  cells  were  fused 
with  t07  SP2/0  cells at  room  temperature  using  50%  wt/vol  PEG  (3,500  mol  wt)  in 
DMEM  containing  15%  DMSO  (19).  Cells were  washed after fusion and  plated out to 
three  96-well  microtiter  plates  in  HAT  selective  media.  Hybrids  were  kept  in  HA]" 
nledium for  10 d, then maintained in HT only for a further  10 d. Usually 10-14 d after 
fusion, wells containing hybrid cells required splitting, and at this stage the supernatants 
were collected and assayed for the presence of antibody to SV40-transformed fibroblasts. 
Positive bybrids were  cloned twice at  limiting dilution, and  subclones of interest were 
grown in large quantities, culture fluids were saved and cells were transferred to (BALB/ 
c x  C57BL/6)F1 pristane-primed mice for the production of ascites fluid. 
Preparation of Cellular  Immunoabsorbents.  Target  cells (SV40-transformed  fibroblast 
cell  lines  and  MC57)  were  harvested  by  treating  with  0.25%  trypsin  EDTA  (Flow 
Laboratories, Ingelwood, CA) for 4-7 min at 37°C, and washed with DMEM. Cells were 
then  transferred  to  flat-bottom polyvinyl chloride tissue culture-treated 96-well  plates 
(Costar 2596) at 2 x  10 ~ cells/well in 200 #1 of DMEF. The plates were incubated in  10% 
(102  for  12-24  h,  or until a  confluent monolayer was obtained in all wells. They were 
then fixed in 0.15%  glutaraldehyde at room temperature for  15 rain, washed with PBS, 
and treated with 0.2 M glycine for 10 rain. The wells were washed and  10% horse serum 
(HS) in PBS was added as a blocking agent. 
Primary kidney fibroblast solid-phase RIA plates were prepared by a modification of a 
previously described technique (9). Kidneys were sterilely removed from C57BL/6  mice 
1 wk or less after birth, teased apart, and incubated with 2.5 ml 0.25% trypsin per kidney 
for  10 rain at room temperature with stirring. The cells were then incubated for 4-6 h 
in  5  ml 0.25%  trypsin per kidney in  the cold. The  resultant turbid cell suspension  was 
filtered  through  nylon  mesh,  washed  twice  with  DMEF,  and  transferred  into  tissue 
culture-treated,  flat-bottom,  polyvinyl chloride 96-well  plates,  grown  and  fixed as de- 
scribed above. 
Solid  Phase RIA.  Supernatants  or  ascites  fluids  were  assayed  for  the  presence  of 
antibody by solid-phase RIA as previously described (8,  9,  20).  Briefly, 25 Ul of culture 
fluids or appropriate dilutions ofascites fluid were added to the cellular immunoabsorbent 
plates described above and allowed to incubate at room temperature for 2-3 h. The plates 
were  rinsed with  10%  HS,  rabbit anti-mouse Ig reagent was added for 2  h,  the plates 
were  rinsed again  witb  10%  HS,  and  incubated  with  ~25I-labeled affinity-purified goat 
anti-rabbit Ig antibody overnight at  room  temperature.  The  plates were  then  washed 
b  n  and counted  in a  gamma counter.  5F1, an  mAb specific for K  , a  d  PAB  100,  an mAb 
specific for SV40  large T  molecule were  used as standards in the assays to assure equal 
expressioH of" these antigens on the surface of the cellular immunoabsorbent plates. 5FI 
was  obtained  from  Dr.  I,inda Sherman  (Scripps Clinic and  Research  Foundation) and 
PAB  100  was obtained from  The  American Type Tissue Culture  Collection, Bethesda, 
MD. 
The  L  chain and  H  chain isotype of the mAb were determined in an  RIA similar to 
that described above but with  rabbit anti-mouse class-specific antibodies in place of the 
rabbit anti-mouse Ig. 
This RIA method was modified to use biotinylated SV40-B6-specific hybridoma anti- 
bodies  (see  below)  and  J~51-1abeled  streptavidin  for  additional  studies  of the  binding 
specificities of these antibodies. 
Antibody-dependent  Complement  Mediated  Cytotoxicity.  Hybridoma  SV40-B6-specific 
mAb  were  tested  for  fine  specificity by  a  standard  antibody-dependent  complement- FROSCHER  AND  KLINMAN 
TABLE  I 
Monoclonal Responses to SV40-B6 
199 
Donor cells*  Recipient 1: 
SV40,B6  +'~  +  +  + 
MC57  -  -  -  + 
Total cells  Overall frequency 
SV40.A(5R)  +  +  -  +  or - 
(X 106)  !  per 106 cells  I  SV40-HTG  +  -  +  -or+ 
Specificity:  SV40  SV40-K  b  SV40-O  b  K b or O b 
C57BL/6 Sp  C57BL/6  250  0.276  14"* (20)  ~  37 (54)  12 (17)  6  (9) 
C57B[./6 slg-  C57BL/6  750  0.071  2l (40)  23 (43)  8 (15)  1 (2) 
BALB/c Sp  BALB/c  1,900  0.212  66 (16)  180 (45)  74 (18)  82 (20) 
BALB/c slg-  BALB/c  1,200  0.030  7 (19)  15 (42)  7 (19)  7 (19) 
*  Donor mice were 2-4 mo old. 
Recipient  mice were primed with  107 irradiated (3,000 tad) SV40-B6 cells i1~ alum 4-6 wk before use.  They received  1,300 rad  1-4 h 
before donor cell transfer, and  107 irradiated (3,000 rad) SV40-B6 cells in saline 1-2 h after donor cell transfer, 
Each recipient mouse received 5.0 ×  107 donor cells. 
I Antibody-producing  clones were detected  by  RIA of culture fluids collected from days 9-24 of culture. They were considered positive if 
their binding to SV40-B6-coated plates was 2  SD above background binding to plates coated with  10% horse serum. 
q An mAb was considered positive if subsaturating amounts of antibody bound target cell plates at least 50% as well as to SV40-B6 cell plates, 
and negative if it bound  target cell plates <20% as well as SV40.B6 cell plates. 
** Total number of monoclonal  responses of the given specificity. 
Numbers in parentheses are percentages of the total SV40-B6 responses producing antibodies of the given specificity. 
mediated  cytotoxicity procedure  using  trypan  blue exclusion  and  cell  visualization  to 
assess killing efficiency (21). 
Antibody Biotinylation and  Fluorescence Analysis.  Hybridoma SV40-B6-specific  mAb 
were precipitated with 50% saturated ammonium sulfate (SAS), resuspended, and passed 
over a Sepharose 6 B column. Purified antibodies were then biotinylated as described by 
Katonia  et al.  (22). Biotinylated  antibodies were then  used in conjunction with fluores- 
ceinated  avidin  (Sigma Chemical  Co.,  St.  Louis,  MO),  for  visual screening  using  a 
fluorescence microscope. 
Results 
Frequency of C57BL/6 Splenic and slg- Bone Marrow Precursor Cells Responsive 
to Antigens Expressed on SV40-B6.  Results of an analysis of SV40-B6-responsive 
cells  in  C57BL/6  spleen  and  sIg-  bone  marrow  cells  in  the  splenic  fragment 
culture system are summarized in Table I. The frequency of C57BL/6 primary 
splenic  B  cells  responsive  to  SV40-B6  stimulation  in  the  syngeneic  C57BL/6 
environment was 2.76 per 107 injected cells. In other antigen systems, responses 
are markedly enhanced by transferring  donor cells to recipients that are alloge- 
neic  to  the  donor  cells  in  the  allotype-idiotype locus  (IgH),  thereby avoiding 
idiotype-specific  suppression  induced  by  the  priming  of recipient  mice  (20). 
However, the response to SV40-B6 by C57BL/6 primary splenic B cells was not 
enhanced by stimulation  in the IgH allogeneic C3H.SW environment  (data not 
shown); therefore, all further studies were carried out in the syngeneic environ- 
ment.  Assuming that  40%  of the  injected spleen cells are B cells, and  that  the 
efficiency of homing  and  stimulation  in  splenic fragment  culture is 4%, as has 
been  previously  determined  (23),  and  since  2.76  of  every  10 v  spleen  cells 
responded to SV40-B6, it can be calculated that  1 of every 5.3 X  104 C57BL/6 
splenic B cells was specific for SV40-B6 cells. 
To  further  define  the  specificity  of  mAb  produced  by  C57BL/6  primary 
splenic B cells in response to SV40-B6 stimulation,  we assessed their binding to 
SV40-B6 (Kbob), MC57 (chemically transformed Kbob), SV40-A(5R) (Kbod), and 
SV40-HTG (KdD  b) (see Table I). 20% of the mAb bound SV40-B6, SV40-A(5R), 200  MHC-RESTRICTED  ANTIBODIES  AGAINST  SV40-TRANSFORMED  CELLS 
and SV40-HTG, but not MC57 cells, and therefore were potentially specific for 
antigens  associated with  SV40  transformation  per  se,  or  for  these antigens  in 
conjunction with nonpolymorphic cell surface antigens. A small percentage (9%) 
of the  antibodies  bound  both  the  H-2  ~ cell  lines,  SV40-B6,  and  MC57,  and 
either,  but not both, the SV40-A(5R) or the SV40-HTG cell  lines.  Therefore, 
these antibodies might have been specific for self H-2 antigens per se, or for H- 
2 antigens  in  conjunction  with  other cell  surface antigens.  Alternatively,  these 
antibodies might actually be specific for antigens associated with SV40 transfor- 
mation  in  conjunction  with  MHC antigens,  but have sufficient affinity for self 
MHC per se to bind in a solid-phase RIA. In any case, since these mAb apparently 
have specificity for self MHC alloantigens, they are currently being characterized 
in greater detail. 
The  vast majority  (71%)  of C57BL/6  primary  splenic  B  cells responsive  to 
SV40-transformed syngeneic cells produced antibodies that bound SV40-B6 but 
not  MC57,  and  only  one  of the  two SV40-transformed  H-2 recombinant  cell 
lines,  SV40-A(5R)  or  SV40-HTG,  but  not  both.  These  antibodies,  therefore, 
apparently were MHC restricted in their recognition of antigens associated with 
SV40 transformation.  The majority of these mAb, representing 54% of the total 
response, bound SV40-A(5R) but not SV40-HTG, suggesting Kb-restricted rec- 
ognition.  The  minority  (17% of the total response) bound SV40-HTG but not 
SV40-A(5R), indicating a Db-ended restriction. 
When  C57BL/6 sIg- bone marrow cells were stimulated  with  SV40-B6,  the 
frequency of responsive cells  was  7.1  per  108  injected  cells.  The  ratio  of the 
frequencies of SV40-B6-responsive cells in C57BL/6 sIg- bone marrow vs. spleen 
was 0.26, which is within the range of ratios of frequencies of responses of sIg- 
vs. spleen cell populations for numerous antigens studied to date, including DNP, 
PC, and the hemagglutinin  of the PR8 influenza virus (24-26). The percentage 
of SV40-B6-specific  C57BL/6  sIg-  bone  marrow  cells  with  each  recognition 
specificity defined above is similar to the percentage of responsive spleen cells of 
similar fine specificity. Thus, the frequency and specificity distribution of C57BL/ 
6 splenic B cells responsive to SV40-B6 cells appear to reflect the specificities of 
newly  generated  bone  marrow  precursor  cells  and  do  not  evidence  marked 
effects of environmental  selective processes. 
Frequency of BALB/c Splenic and slg- Bone Marrow B Cells Responsive to Antigens 
Expressed  on  SV40-B6.  The  frequencies  of BALB/c primary  spleen  and  sIg- 
bone marrow cells responsive to SV40-B6 cells in splenic fragment culture were 
21.2  and  3.0  per  108  injected  cells,  respectively (see Table  I).  Therefore,  the 
overall frequency of B cells or B cell precursors responsive to SV40-B6 cells in 
spleen cell and sIg- bone marrow cell populations is similar for mice a]logeneic 
to the stimulating cell, and for mice syngeneic to the stimulators.  Furthermore, 
an analysis of the fine specificity of mAb from SV40-B6-responsive BALB/c cells 
from  both  spleen  and  slg-  bone  marrow  cell  populations  showed  a  similar 
representation  of the  different  specificities as  found  in  the  precursor  cells  of 
syngeneic C57BL/6 mice. The majority (61-63%) of the antibodies bound SV40- 
B6  but  not  MC57  and  only  bound  either  SV40-A(5R)  or  SV40-HTG  and 
therefore appeared to be specific for cells bearing both SV40-specific transfor- 
mation antigens and either  K b or  D b molecules. Of those, most were specific for FROSCHER  AND  KLINMAN  201 
TABLE  II 
Hybridomas Specific  for SV  40-transformed Cells 
Hybrid*  lsotype*  Specificity  + 
SV40 fibroblasts (determined by RIA)  jl 
bml  bm3  bm8  bml0  bmll 
SV4  ~t, x  SV40-K  b (1)  -  +  -  -  + 
SV27  #, x  SV40-K  b (1, 3)  -  -  +/-  +  + 
SV30  u, ~  SV40-K  b (1)  -  +  -  -  - 
SV36  /~, K  SV40-D  b (1, 2, 3)  ND  ND  ND  ND  ND 
SV37  ~2bK  SV40°K  b (1, 3)  -  -  +/-  +  + 
SV101  ~'2bx  SV40-K  b (1, 2, 3)  -  +  +  +  + 
SV103  ~,2bx  SV40 (1, 2, 3)  +  +  +  +  + 
SV 154  ~,2bK  SV40-K  b (1, 3)  -  -  -  +  - 
SV311  u, ~  SV40 (1,2, 3)  ND  ND  ND  ND  ND 
* Hybridoma cell  lines produced by the transfer fusion protocol from C57BL/6 primary spleen cells. 
* Isotype detected by RIA. 
§ Cell surface molecule(s) apparently necessary for the binding of that mAb as determined by discrimination 
between  SV40-B6,  MC57,  SV40-A(5R),  and  SV40-HTG  in  the  following  assay  systems:  1,  RIA;  2, 
antibody-dependent complement-mediated cytotoxicity; 3, biotin-avidin fluorescence. 
II SV40-transformed fibroblast cell lines with the given MHC haplotype obtained from Dr. B. Knowles. 
cells bearing  the  K b molecule in  that  they bound SV40-A(5R) and  not SV40- 
HTG.  A small percentage (16-19%) of all  responsive cells produced antibodies 
that bound all three SV40-transformed cell lines but did not bind the chemically 
transformed line MC57, and therefore appeared to require only SV40 transfor- 
mation-associated antigens for recognition and binding.  The remaining respon- 
sive cells (~20%)  bound both  the  H-2  b cell  lines (SV40-B6,  MC57) and  either 
the SV40-A(5R) or the SV40-HTG cells, but not both, and therefore appeared 
to be specific for H-2  b molecules per se. 
Characteristics of SV40-B6-specific Hybridoma Antibodies.  Since  the  quantities 
of mAb available from fragment cultures are limited (0.1-2 ~tg), we constructed 
hybridoma cell lines that secrete SV40-B6-specific antibodies for use in extensive 
specificity, function, and structure analyses. These hybridomas were obtained by 
transfer fusions (see Materials and Methods) in which irradiated antigen-primed 
recipient  mice  provided  an  appropriate  milieu  for  responses  of transferred 
primary  B cells.  Hybridomas and  their  subclones were selected on the basis of 
the  capacity  of their  antibody  products  to  bind  SV40-B6  fibroblasts  but  not 
MC57  fibroblasts,  thus  excluding  all  antibodies  that  bound  nonspecifically  to 
cultured cell  rnonolayers,  as well as rare  antibodies  that  bound both  H-2  b cell 
lines equally and therefore did not require SV40 transformation  for binding.  In 
all, nine hybridomas were selected from four separate fusions (see Table II). The 
participation  of antigens associated with  SV40 transformation  in the specificity 
of all of these antibodies was further confirmed by the relatively poor binding 
of these  antibodies  to  H-2 b primary  kidney  fibroblasts  under  conditions  that 
permitted binding by the anti-H-2 b antibody product of the Y3 hybridoma cell 
line (data not shown). 
Two of the nine mAb, SV103 and SV311, bound equally well to SV40-A(5R) 
and SV40-HTG cells, as well as to the stimulating cell line SV40-B6. The other 
seven  preferentially  bound  either  SV40-A(5R)  or  SV40-HTG,  but  not  both. 
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of the  target  cell  apparently  contributed  to  antigen  recognition.  SVI03  and 
SV311  may represent antibodies specific for either SV40  transfbrmation-asso- 
ciated antigens per se, or for these antigens in the context of cell surface antigenic 
determinants common to both H-2 ~' and H-2  '~ cells. 
Table  II shows that six of the mAb bound SV40-A(5R)  as well  as  or better 
than the immunizing cell line SV40-B6, and failed to bind significantly to SV40- 
HTG.  This strongly suggests that the  K  ~' glycoprotein is  the  significant H-2 b- 
encoded molecule for the recognition specificities of these antibodies. In contrast, 
SV36 bound well to SV40-HTG but not to SV40-A(5R), suggesting that the D  h 
glycoprotein is the significant H-2b-encoded molecule for the recognition speci- 
ficity of this antibody. Thus,  consistent with the findings described above for 
splenic fragment culture experiments, while some C57BL/6 B cells do respond 
to antigens associated with SV40  transformation per se,  the recognition of the 
majority of responding B cells is associated with the expression of H-2 ~ molecules 
on the transformed cells, and most frequently with the expression of the H-2K  b 
molecule. 
To further confirm the recognition specificities of these mAb, many of them 
were  used  in  two  additional  assay  systems:  antibody-dependent complement- 
mediated cytotoxicity, and biotin-avidin fluorescence staining. In each case, when 
an antibody was  tested by multiple assay systems, its  recognition specificity as 
determined by each assay was the same (see Table II). In all three assay systems 
used, a quantitative effect on specificity was identified. At high antibody concen- 
trations, some but not all of the tested antibodies bound non-SV40-transformed 
B6 cells (MC57). To further analyze this, a fourth assay system was devised using 
biotinylated purified SV40-B6-specific hybridoma antibodies in an RIA in which 
J2~'l-labeled streptavidin was used to detect binding. This assay proved beneficial 
for  two  reasons.  First,  both  the  consistency  and  signal  to  noise  ratio  were 
enhanced, presumably because of the elimination of nonspecific binding of the 
rabbit  anti-mouse and  goat anti-rabbit antibodies to  the  cellular immunoab- 
sorbents. Second, it allowed for competitive inhibition studies using nonbiotiny- 
lated antibodies as inhibitors. 
Fig.  1 shows two characteristic binding curves of SV40-Kb-specific  hybridoma 
mAb on SV40-B6 or MC57 cells. SV 101 bound SV40-B6 cells significantly better 
than MC57, and did not show increased binding to MC57 with higher concen- 
trations of antibody. In contrast to this, SV30 at high concentrations bound both 
SV40-B6  and  MC57  cells,  however  at  lower  concentrations,  its  binding  was 
markedly better on SV40-B6 than on MC57. 
Fine Spec~city  of SV40-B6-spec~c  Hybridoma Antibodies.  Using  a  panel  of 
SV40-transformed cell lines bearing mutational variants of the H-2K  b molecule, 
the fine specificity of the SV40-B6-specific hybridoma antibodies was studied by 
RIA (Table  II).  One of the two antibodies that failed to discriminate between 
SV40-A(5R) and SV40-HTG cells,  SV103,  also failed to discriminate between 
tbe  SV40-transformed  K b  mutant cells  in  that it bound all  tested SV40-trans- 
formed cells equally well.  The other antibody specific for SV40 transformation 
antigens per  se,  SV311,  and mAb SV30,  which required both  SV40  transfor- 
mation and D  h molecules for cell binding, were not tested on the panel of SV40- 
transformed  K  b mutants.  The  remaining six  mAb,  which  bound  only SV40- 70- 
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FZGURE  1.  Solid phase RIA of biotinylated SV40-B6-specific hybridoma antibodies on SV40- 
B6 (O) and MC57 (©) fibroblast target cells. The biotinylated antibodies were added in several 
dilutions, and binding was detected by the addition of ~eSl-labeled  streptavidin and counting 
in a  gamma counter. Inhibition of binding by a  10-fold excess of unbiotinylated homologous 
antibody (11) is given at one dilution point. A, SV101; B, SV30. 
transformed  cells  bearing  the  H-2K  b molecule,  all  discriminated  among  the 
different SV40-transformed K  b mutant cell lines and defined five distinct patterns 
of reactivity.  Two  of the  mAb,  SV27  and  SV37,  which  were  derived  from 
separate fusions, displayed a similar reactivity pattern in that they bound SV40- 
bml0  and  SV40-bml 1  well,  SV40-bm8  moderately well,  and  failed  to  bind 
SV40-bml  or  SV40-bm3.  The  remaining  four  mAb  each  defined  a  unique 
reactivity pattern  on  the  five  tested  K  b mutant  SV40-transformed  cell  lines. 
However, none of the six Kh-restricted antibodies bound SV40-transformed cells 
bearing the bm 1 K  b mutation. Interestingly, the binding of many of the mono- 
clones is  disrupted by  mutations in  more  than  one of the domains of the  K  b 
molecule (27).  For example, SV40 does not bind bml  or bml0, both of which 
have mutations only in the second domain, but it also does not bind bm8, which 
has mutations only in the first domain. It does, however, bind bin3 and bml 1, 
which also have only first-domain mutations. 
Discussion 
Recognition of cell  surface antigens in the context of self MHC alloantigens, 
and  therefore immune surveillance for vira]ly infected or  neoplastic cells  has 
long been considered the province of T  cells (1-3). Findings previously reported 
by  this  laboratory  (8,  9)  showed  that  a  significant proportion  of the  B  cells 
responsive  to  influenza  (PR8)-infected  MHC-syngeneic  cells  produced  mAb 
uniquely specific for MHC-syngeneic infected cells  (self +  X  recognition). The 
present studies were designed to assess the role of self +  X recognition in the B 
cell response to SV40-transformed H-2  b ceils. 
SV40-transformed cells present a complex cell surface antigenic mosaic to the 
immune system. In addition to normal cell surface proteins, including self MHC 
molecules, these ceils express cell surface antigens unique to SV40-transformed 
cells (e.g., large T  protein and nonviral T  proteins [NVT or p53]), and possibly 
others common to transformed cells in general (28-32).  Studies using cytotoxic 
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proteins with transformation-associated proteins for effective T  cell recognition 
of these cells (12-14, 33-35). Studies of the humoral antibody response to SV40- 
transformed  cells  have  generally  been  conducted  under  conditions  that  only 
allow for recognition of antibody responses to transformation-associated antigens 
per se (36-39).  Recently, however, a hybridoma antibody generated in response 
to  SV40-B6  cells has  been  shown  to  effectively block a  cytolytic T  cell  clone 
specific for large T  protein and the H-2K  b molecule (40). 
The frequency of primary splenic H-2  b B cells responsive to SV40-transformed 
H-2 b fibroblasts in splenic fragment culture and  whose antibody products bind 
only SV40-transformed cells bearing MHC gene products of the immunizing cell 
line  is  1.2  per  105  B  cells.  This  is  similar  to  the  previously  observed  (8,  9) 
frequency of MHC-restricted responses to PR8-infected H-2  b fibroblasts. Signif- 
icantly, while a majority of B cells responsive to PR8-infected H-2  b cells required 
viral antigen expression on syngeneic cells, an even greater proportion (71%) of 
B  cells  responsive  to  SV40-B6  produced  antibodies  that  bound  only  SV40- 
transformed syngeneic cells. 20% of the C57BL/6 mAb produced in response to 
SV40-B6 antigens  bound both SV40-A(5R) and  SV40-HTG.  These antibodies 
include all antibodies specific for SV40 transformation-associated  antigens per 
se, as well as any that  recognize these antigens  in conjunction  with cell surface 
determinants  common  to the  H-2  b and  H-2  a fibroblast target  cells. Therefore, 
at  most,  20%  of  primary  C57BL/6  splenic  B  cells  responsive  to  SV40-B6 
fibroblasts recognize SV40 transformation-associated  antigens per se.  Another 
9% of the responsive cells recognized cell surface antigens associated with H-2  b 
cells, did but did not require SV40 transformation-specific antigens for binding. 
Because  the  above  findings  indicated  that  the  in  vitro  monoclonal  B  cell 
response  to  transformed  cells may be dominated  by self +  X  recognition,  we 
carried out an  independent  assessment of the primary  C57BL/6 splenic  B cell 
recognition of SV40-B6 as defined by SV40-B6-specific hybridomas. The results 
of an analysis of the specificities of nine hybridoma antibodies from four separate 
fusions,  selected  only  on  the  basis  of  their  capacity  to  discriminate  SV40- 
transformed  H-2  b cells  from  non-SV40-transformed  H-2  b cells,  was  entirely 
consistent  with  the  much  larger  survey  of specificities  obtained  by  fragment 
culture technology.  Of the nine  hybridoma antibodies analyzed,  the specificity 
of seven could be attributed  to complex  recognition  of SV40  transformation- 
specific  antigens  in  association  with  self  MHC  products.  Six  of these  seven 
recognized only SV40-transformed  cells bearing the  K b molecule, and further- 
more,  these  six  antibodies  differentiated  among  several  SV40-transformed  H- 
2K  b mutant  cell  lines,  thereby  defining  at  least  five  different  fine  specificity 
patterns.  These data confirm that the recognized self components are encoded 
by the MHC, and indicate that the B cell response to SV40-transformed syngeneic 
cells  is  dominated  by a  diverse  population  of B  cells  whose  Ig  receptors and 
potential antibody products are specific for self MHC +  foreign X recognition. 
The present data extend to a  second cell surface antigen  complex the  unex- 
pected  observation  of a  predeliction  of  B  ceils  for  MHC-restricted  antigen 
recognition.  Other  laboratories  have  described  (7,  10,  11)  human  myeloma 
proteins  with  restricted  recognition  for  male  antigens  and  murine  serum  re- 
sponses  to  male  antigens  and  Sendai  virus-infected  cells  that  exhibit  varying FROSCHER AND KLINMAN  205 
degrees of self MHC-restricted recognition. Taken as a  whole, these findings 
suggest that self +  X  recognition, rather than being atypical, may in fact be a 
significant and integral characteristic of the B cell repertoire in its response to 
cell surface antigens, and that these specificities have not been identified more 
frequently due to the lack of experiments adequately constructed for this pur- 
pose. 
mAb obtained from both in vitro stimulation and hybridomas displayed a clear 
preference for recognition of SV40-associated transformation antigens in con- 
junction with  K b  molecules. This preferential  Kb-ended restricted recognition 
may reflect any of a number of underlying mechanisms similar to the proposed 
mechanisms for the immune response (lr) gene effect on T  cell repertoire (41- 
43). These include environmental repertoire determination or differing associ- 
ative capacities of given class  I  molecules with  SV40  transformation antigens. 
Since SV40-A(5R)  and  SV40-HTG  are  recognized equally well  by  SV40-B6- 
specific CTL (12,  13),  the relatively poor recognition by H-2 b B cells of SV40- 
HTG  may be construed to  reflect environmental determination of restricted 
recognition by B cells.  However, two findings presented in  this paper suggest 
that this preference for Kb-ended restricted recognition does not reflect environ- 
mental molding of the B cell repertoire. 
First, the distribution of recognition specificities and the overall frequency of 
SV40-B6-responsive  primary  splenic  B  ceils  is  similar  in  BALB/c  (H-2  d) and 
C57BL/6 (H-2  b) mice. In both cases, the majority (63 and 71%, respectively) of 
responsive B cells are H-2 restricted in their recognition of SV40 transformation- 
associated antigens, and most commonly, the restriction appears associated with 
the K b molecule. Therefore, unlike many instances in T  cell repertoire expres- 
sion,  wherein  preference for  self +  X  recognition  restricted by  given  MHC 
alloantigens appears  dependent on  the developmental environment of T  cells 
(12, 43, 44), there is no obvious Ir gene effect due to the MHC developmental 
environment of the B cells in their response to SV40-B6 cells in the two strains 
studied. 
Second, evidence for the lack of environmental modulation of this response is 
provided by the results from the analyses of slg- bone marrow cells from C57BL/ 
6 and BALB/c mice in splenic fragment cultures. In both strains, the frequency 
ratio of sIg- bone marrow to splenic SV40-B6-responsive cells is consistent with 
the similar ratio for several other antigens studied to date, including influenza 
virus PR8 antigens, PC, and DNP (24-26)  suggesting that little modulation of 
the response has taken place during maturation of the B cells in vivo. Further- 
more, the distribution of specificities is similar in the responsive sIg- bone marrow 
and splenic precursor cells, again  suggesting limited environmental effects on 
the establishment of the expressed SV40-B6-specific repertoire. 
The seven hybridoma antibodies that recognize SV40-associated antigens in 
conjunction with H-2 b molecules should prove extremely useful in defining the 
molecular basis  of complex  antigen  interactions,  and  studies  to  pursue  these 
questions have been initiated. Some conclusions can already be drawn from the 
findings presented in  this  paper.  The structure of antibody-combining sites is 
well established,  and  although  the determinant interaction  sites  can be  quite 
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fication of MHC-restricted antibodies serves as an unambiguous demonstration 
that a single combining site can accomplish complex antigen recognition. 
Postulates for the molecular basis of MHC-restricted antigen recognition by a 
single combining site include (a) the corecognition of determinants on both the 
foreign antigen and the MHC molecules, (b) the recognition of conformations of 
the foreign antigen  induced  by its interaction  with an  MHC molecule, and  (c) 
the recognition of conformations of an MHC molecule induced by its interaction 
with  the  foreign  antigen  (48-50).  Evidence  has  been  presented  by  several 
laboratories  (12,  13,  51-53)  showing  the  potential  for  physical  association  of 
MHC molecules and  antigens,  a  finding  consistent with  all  three  of the above 
postulates.  Since  the  cell  surface antigenic  determinants  associated with  SV40 
transformation  are poorly defined, the findings presented herein  are relatively 
uninformative  concerning  the  first  two  postulates.  However,  several  of our 
findings are of interest  in  this question.  First,  the binding  of some hybridoma 
antibodies to SV40-transformed  cells is disrupted  by spatially separated  H-2K  b 
mutations  (e.g.,  SV4,  SV27;  see  Table  II).  This  may  imply  participation  of 
conformational  H-2  determinants  in  either  antigen  presentation  or  immune 
recognition  (50).  Second,  none  of the  SV40-Kb-specific hybridoma  antibodies 
bind SV40-transformed cells bearing the bm 1 mutant.  This finding is similar to 
the findings (12,  13) with SV40-K  b specific CTLs, which have been attributed to 
bml  being  nonassociative  with  SV40  transformation-associated  antigens.  An- 
other possibility, however, is that the interaction of SV40 transformation antigens 
and  K b molecules bearing  the  bml  mutations  do not result  in  conformational 
changes necessary  for  recognition  by lymphocytes.  Finally,  at  high  concentra- 
tions, some SV40-Kb-specific mAb are capable of variable degrees of binding to 
H-2K  b in  the absence of SV40 transformation  antigens.  It is  possible that  this 
binding may reflect the ability of these antibodies to induce a conformation  of 
the  H-2 molecule similar to a  conformation  induced  by association with  SV40- 
associated  antigens.  This  induced  fit  model  has  previously been  proposed  to 
explain the low-affinity binding of anti-synthetic peptide antibodies to the native 
protein  from which the peptide sequence was derived (54, 55). As studies with 
these  antibodies  progress,  these  and  similar  issues  could  be  resolved  at  the 
molecular level. 
Taken as a whole, the results of studies using mAb derived from both splenic 
fragment  cultures  and  transfer  fusions  are  compatible  in  that  they  show  an 
extraordinary  predilection  for recognition  of SV40  transformation-associated 
antigens in conjunction with  K h molecules, and only a very low proportion of B 
cells that  recognize  cell  surface antigens  associated  with  SV40  transformation 
per se, or these antigens in conjunction with cell surface determinants  common 
to H-2  b and H-2  'j cell fines.  The two hybridoma antibodies that display this latter 
recognition  are currently  being tested for their capacity to bind  isolated SV40 
transformation-associated  antigens.  The  availability  of large  amounts  of anti- 
SV40-B6 hybridoma antibodies should also ultimately provide a  means for: (a) 
studying the idiotypic composition of an anti-self +  X repertoire, (b) evaluating 
the biological effects of anti-self +  X  antibodies on T  cell repertoire  develop- 
ment,  stimulation,  and  effector function,  and  (c)  the  affinity  purification  and 
analysis of the cell surface components contributing to the recognition site.  It is FROSCHER  AND  KLINMAN  207 
clear  from  the  studies presented  herein  that,  for certain  cell  surface  antigens 
including antigens associated  with  transformation, self +  X  recognition  is  the 
primary mode of recognition for B cells and antibody as well as for T  cells. Given 
the obvious physiological significance of such recognition, it will be important to 
assess  the  role  of self +  X  recognition  in  both  the  evolutionary and  somatic 
shaping of B cell repertoire expression. 
Summary 
Recognition  of antigens  on  cell  surfaces  only in  the  context  of the  MHC- 
encoded alioantigens of the presenting cell (self +  X) has classically been consid- 
ered  the  province  of  T  cells.  However,  evidence  from  several  sources  has 
indicated that B ceils and antibodies can exhibit self +  X-restricted recognition 
as  well.  This  report  concerns  the  mAb  response  to  SV40-transformed  H-2 b 
fibroblast  cell  lines.  The  specificities  of  the  antibodies  obtained  have  been 
analyzed for binding to a  panel of SV40-transformed  H-2-syngeneic, H-2-allo- 
geneic, and H-2 b mutant fibroblast cell lines, as well as cell lines not bearing celt 
surface SV40 transformation-associated antigens. A large proportion of primary 
C57BL/6  (71%)  and  BALB/c  (68%)  splenic  B  cells  responding  to  in  vitro 
stimulation  with  SV40-transformed  H-2 b cells  recognize  cell  surface  antigens 
associated with SV40 transformation only when coexpressed with MHC antigens 
of the immunizing cell, particularly the K b molecule, on transformed cells. To 
extensively define the nature of antigen recognition by these antibodies, we have 
generated and characterized nine hybridoma antibodies specific for SV40-trans- 
formed H-2-syngeneic cell lines. Seven of these hybridoma antibodies recognize 
SV40-associated  transformation antigens in the context of H-2 b molecules.  Six 
of these are  restricted by the  K b  molecule and discriminate among a  panel of 
SV40-transformed  K b mutant cell lines, thus confirming the participation of class 
I MHC-encoded molecules in the recognition by B cells of cell surface antigens. 
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